Day: November 29, 2023

Ambulatory Healthcare Professionals from Across the U.S. Gather in Orlando to Explore How Technology Can Maximize Patient Outcomes

During 140+ Sessions, UGM23 Attendees will Learn about AI-Driven Ambient Listening to Reduce Physician Burnout and other HealthTech InnovationsREMOTE-FIRST COMPANY/ORLANDO,...

Rocket Doctor and Engagewell IPA Win New York Health Foundation Grant to Expand ‘Healthcare in Housing’ for Residents in Inner-City NY

Partnership Lets Patients in Supportive Housing Access Comprehensive Virtual Primary Care and Mental Health Services, Powered by Device Kiosks and...

Clairvoyant Surpasses 50 Per Cent Randomization in its Phase 2b Psilocybin Therapy Trial for Alcohol Use Disorder

VANCOUVER, BC / ACCESSWIRE / November 29, 2023 / Clairvoyant Therapeutics Inc. (www.clairvoyantrx.com), the clinical-stage pharmaceutical company developing psilocybin therapy...

Dyadic Announces Top-Line Results from its Successful Phase 1 Clinical Trial for a First-in-Human Filamentous Fungal-Based Vaccine Candidate

Primary endpoint met Demonstrated safety and reactogenicity of DYAI-100 recombinant proteinC1-cell produced antigen was both safe and well-toleratedNo Serious Adverse...

Interim Results from Ongoing Clinical Study Confirm EB613 Optimized Profile for Osteoporosis Treatment and Potential for Entera’s Next Generation Oral Peptide Platform

JERUSALEM, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the...

Oxford BioTherapeutics Announces Partner Boehringer Ingelheim Received U.S. FDA Fast Track Designation for BI 764532 for the Potential Treatment of Advanced or Metastatic Large-Cell Neuroendocrine Carcinoma of the Lung

error: Content is protected !!